Salt Lake City, Utah, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company focused on cellular activation, has announced that its President and Chief Executive Officer, Steve Fife, will retire in April 2026 after nine years of dedicated leadership.
Fife will continue serving as CEO during the transition period to ensure stability and business continuity while the Board conducts a comprehensive search for his successor.
The Board of Directors has already initiated an extensive executive search process and expects to announce the new CEO in the coming months.
According to Raymond Greer, Chairman of the Board, the company has been carefully preparing for this transition through long-term succession planning.
Greer highlighted that this structured approach ensures operational continuity and positions the company for sustained growth in the competitive health and wellness industry.
During his tenure, Steve Fife played a transformative role in strengthening LifeVantage’s business model and expanding its market presence. His leadership focused on operational excellence, consultant engagement, and long-term shareholder value.
Under his guidance, the company evolved strategically while maintaining strong relationships with consultants, customers, employees, and investors. His contributions have built a solid foundation for the next phase of corporate growth.
Fife described leading LifeVantage as one of the most rewarding experiences of his career. He expressed pride in the organization’s achievements, particularly in refining the business model and enhancing the company’s competitive position.
He also shared confidence in the executive team and Board of Directors to successfully guide the company into its next chapter of innovation and expansion.
Founded in 2003 and headquartered in Lehi, Utah, LifeVantage Corporation is recognized as a pioneer in nutrigenomics, the science of how nutrition and naturally occurring compounds influence gene expression and overall health.
The company develops scientifically validated products designed to activate optimal health at the cellular level.
LifeVantage offers a diverse portfolio of activation-focused products, including:
These products are distributed through independent consultants who also provide entrepreneurial business opportunities.
With a structured succession plan in place and a clear strategic vision, LifeVantage remains well-positioned for continued success. As the company prepares for new leadership in 2026, its focus on cellular health innovation, consultant empowerment, and scientific advancement continues to drive long-term growth.
The upcoming leadership transition marks not an end, but the beginning of the next chapter in LifeVantage’s journey toward advancing health at the cellular level.
Get more information
There are no reviews yet. Be the first one to write one.
